Harmony Biosciences Holdings, Inc. Profile Avatar - Palmy Investing

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive day…
Biotechnology
US, Plymouth Meeting [HQ]
HRMY/Financials
Segments · Problems · Premarket · Compliance

Segment Analysis

Segment Analysis
Revenue · By Business Segment
Not available for HRMY
Revenue · By Area
Not available for HRMY
End of HRMY's Analysis
CIK: 1802665 CUSIP: 413197104 ISIN: US4131971040 LEI: - UEI: -
Secondary Listings
HRMY has no secondary listings inside our databases.